Last week, I gave you an overview of the changes coming with the end of the federal public health emergency (PHE). This week, I’d like to focus on the health equity implications of the PHE’s end. With the end of extra supplies and resources tied to the emergency, people who are already vulnerable to other health issues will become more at risk for COVID-19.
Read More
In the last week of December, I had a major story published at MuckRock, USA TODAY, and local newsrooms in Arizona, Oregon, and Texas. The story explains that official COVID-19 statistics underestimate the pandemic’s true toll—particularly on people of color, who are more likely to have their deaths inaccurately represented in mortality data.
Read MoreSources and updates for the week of October 30 include booster shot demographics, mortality data by occupation, Paxlovid prescriptions, and more.
Read More
Unlike previous vaccination campaigns, the new Omicron boosters are available to all adults across the country who have been previously inoculated. But all previously-vaccinated Americans are not facing similar levels of COVID-19 risk.
Read MoreSources and updates for the week of July 3 include race and ethnicity data, COVID-19 spread from a cat, and more.
Read More
Will we ever get control of this pandemic? We can, but better data will go a long way in helping us get there. Here are nine areas where I’d like to see improvement.
Read MoreA recent edition of “The Morning,” the New York Times’ flagship newsletter, painted a misleading picture of COVID-19 disparities in the U.S.
Read More
Sources and updates for the week of June 5 include a new chart on the CDC’s wastewater dashboard and studies showing COVID-19’s disproportionate impact on Native Americans.
Read MoreFeatured sources for the week of May 1 include vaccination rates in nursing homes, neighborhood-level health disparities, access to hospital services, and more.
Read MoreData sources and updates for the week of April 24 include COVID-19 on airplanes, death rates by race and ethnicity, Long COVID research, and more.
Read More